V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10007962 | 10007109 | 1.61 | 72.6 | Adjuvant (A) | 2019-06-30 | 2019-07-01 | Trastuzumab Subcutaneous | 2 | N | 10361500 | TRASTUZUMAB |
| 10007963 | 10003968 | 1.73 | 62.7 | Palliative (P) | 2017-07-11 | 2017-07-28 | PACLITAXEL | N | N | 10361811 | PACLITAXEL |
| 10007964 | 10003970 | 0 | 74 | Curative (C) | 2019-03-28 | 2019-04-22 | FLUOROURACIL + OXALIPLATIN | N | N | 10361864 | OXALIPLATIN + MDG |
| 10007965 | 10009149 | 1.59 | 52.7 | Disease modification (D) | null | 2019-08-01 | Rituximab | N | N | 10362202 | RITUXIMAB |
| 10007966 | 10003971 | 1.71 | 57.8 | null | 2018-09-03 | 2018-09-06 | TRASTUZUMAB | 2 | 2 | 10362264 | TRASTUZUMAB |
| 10007967 | 10003977 | 1.68 | 0 | Palliative (P) | 2019-05-03 | 2019-05-18 | Docetaxel | 2 | N | 10363023 | DOCETAXEL |
| 10007968 | 10003982 | 1.69 | 46.9 | Palliative (P) | 2019-03-09 | 2019-03-16 | Rituximab | 02 | N | 10363722 | RITUXIMAB |
| 10007969 | 10003984 | 1.55 | 108.9 | Palliative (P) | 2016-12-31 | 2017-11-02 | Trastuzumab Subcutaneous | 2 | N | 10363886 | TRASTUZUMAB |
| 10007970 | 10003987 | 1.74 | 89.2 | Curative (C) | 2018-06-12 | 2018-06-12 | Rituximab (Maintenance) | N | N | 10364258 | RITUXIMAB |
| 10007971 | 10003988 | 1.75 | 94 | Palliative (P) | 2019-06-02 | 2019-06-08 | Rituximab | N | N | 10364532 | RITUXIMAB |
| 10007972 | 10003991 | 1.78 | 87.65 | Curative (C) | 2018-02-02 | 2018-07-07 | FLUOROURACIL + IRINOTECAN | N | N | 10364593 | IRINOTECAN + MDG |
| 10007973 | 10003993 | null | 81 | Palliative (P) | 2016-08-15 | 2016-12-31 | Rituximab (Maintenance) | null | null | 10365403 | RITUXIMAB |
| 10007974 | 10007117 | null | 64 | Adjuvant (A) | 2017-04-21 | 2018-05-31 | Rituximab (SUBCUTANEOUS Maintenance) | 2 | null | 10366122 | RITUXIMAB |
| 10007975 | 10003996 | 1.7 | 70.3 | Palliative (P) | 2017-11-02 | 2017-11-04 | Oxaliplatin + Modified de Gramont | N | N | 10366173 | OXALIPLATIN + MDG |
| 10007976 | 10003997 | 1.75 | 86 | Palliative (P) | 2015-10-27 | 2015-11-10 | Rituximab (Maintenance) | 02 | N | 10366268 | RITUXIMAB |
| 10007977 | 10003998 | 1.66 | 80 | Not known (9) | 2017-05-13 | 2017-05-13 | Oxaliplatin + Modified de Gramont | 02 | N | 10366482 | OXALIPLATIN + MDG |
| 10007978 | 10008924 | 1.52 | 70.6 | Palliative (P) | null | 2018-01-08 | Rituximab | 02 | null | 10366608 | RITUXIMAB |
| 10007979 | 10004001 | null | 76.6 | Curative (C) | null | 2017-07-20 | Capecitabine + Oxaliplatin 21day | 02 | N | 10366762 | CAPECITABINE + OXALIPLATIN |
| 10007980 | 10004006 | 1.68 | 75 | Palliative (P) | 2018-08-22 | 2018-08-30 | CHOP R | null | null | 10367228 | CHOP R |
| 10007981 | 10004008 | 1.69 | 77.1 | Palliative (P) | 2018-03-15 | 2018-04-03 | Oxaliplatin + Modified de Gramont | 02 | N | 10367384 | OXALIPLATIN + MDG |
| 10007982 | 10004010 | 1.67 | 61.5 | Curative (C) | 2017-08-04 | 2017-08-18 | PEMBROLIZUMAB | 02 | N | 10367511 | PEMBROLIZUMAB |
| 10007983 | 10004014 | 1.8 | 79.2 | Palliative (P) | 2016-09-23 | 2016-10-22 | PEMBROLIZUMAB | N | N | 10367752 | PEMBROLIZUMAB |
| 10007984 | 10004018 | 1.66 | 78.2 | Curative (C) | 2018-08-27 | 2018-09-12 | Irinotecan + Modified De Gramont | 2 | N | 10368627 | IRINOTECAN + MDG |
| 10007985 | 10004020 | 1.8 | 81.8 | Palliative (P) | 2018-06-17 | 2019-02-11 | Rituximab | N | N | 10368895 | RITUXIMAB |
| 10007986 | 10007127 | null | 66.8 | Palliative (P) | 2016-04-19 | 2016-04-22 | Irinotecan + Modified De Gramont | 02 | N | 10369365 | IRINOTECAN + MDG |
| 10007987 | 10007127 | 1.64 | null | Curative (C) | 2018-11-24 | 2018-11-24 | Docetaxel | N | N | 10369365 | DOCETAXEL |
| 10007988 | 10004023 | 1.76 | null | Palliative (P) | 2018-06-16 | 2018-07-07 | Docetaxel | N | null | 10369490 | DOCETAXEL |
| 10007989 | 10007129 | 1.68 | 110 | Adjuvant (A) | 2017-10-31 | 2017-10-31 | FLUOROURACIL + OXALIPLATIN | N | N | 10369715 | OXALIPLATIN + MDG |
| 10007990 | 10004025 | 1.71 | 69.6 | Palliative (P) | null | 2016-02-01 | TRASTUZUMAB | N | N | 10369958 | TRASTUZUMAB |
| 10007991 | 10004027 | 0 | 122.7 | Palliative (P) | 2018-08-13 | 2018-08-13 | Capecitabine + Oxaliplatin 21day | N | null | 10369972 | CAPECITABINE + OXALIPLATIN |
| 10007992 | 10007131 | null | 100 | Adjuvant (A) | 2017-08-26 | 2017-09-06 | Rituximab | N | N | 10370639 | RITUXIMAB |
| 10007993 | 10004030 | 1.63 | 69.8 | Palliative (P) | 2019-02-05 | 2019-02-11 | Rituximab | 02 | N | 10371112 | RITUXIMAB |
| 10007994 | 10004032 | 1.77 | 67.1 | Disease modification (D) | 2016-07-04 | 2016-07-12 | Docetaxel | N | N | 10371297 | DOCETAXEL |
| 10007995 | 10004032 | null | 89.9 | Palliative (P) | 2017-06-19 | 2017-06-21 | FLUOROURACIL + IRINOTECAN | N | N | 10371297 | IRINOTECAN + MDG |
| 10007996 | 10004033 | null | 72.4 | Palliative (P) | null | 2018-10-25 | CHOP R | N | N | 10371570 | CHOP R |
| 10007997 | 10004035 | 1.59 | 94 | Palliative (P) | 2016-10-09 | 2016-10-09 | Oxaliplatin + Modified de Gramont | 02 | N | 10371903 | OXALIPLATIN + MDG |
| 10007998 | 10004038 | 1.85 | 82.5 | Palliative (P) | 2018-04-04 | 2018-08-19 | Rituximab | N | Y | 10372912 | RITUXIMAB |
| 10007999 | 10007136 | 1.77 | 70.2 | Palliative (P) | 2019-01-22 | 2019-01-31 | CHOP R | 02 | N | 10372946 | CHOP R |
| 10008000 | 10004041 | 1.7 | 57.9 | Disease modification (D) | 2018-07-08 | 2018-07-08 | Irinotecan + Modified De Gramont | N | null | 10372986 | IRINOTECAN + MDG |
| 10008001 | 10004043 | 1.83 | 77.1 | Palliative (P) | 2015-10-22 | 2015-10-22 | Oxaliplatin + Modified de Gramont | 02 | N | 10373083 | OXALIPLATIN + MDG |
| 10008002 | 10004046 | null | 87 | null | 2019-04-12 | 2019-04-11 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 10373289 | PACLITAXEL |
| 10008003 | 10004047 | null | null | Palliative (P) | 2016-04-27 | 2016-05-17 | PEMBROLIZUMAB | N | N | 10373356 | PEMBROLIZUMAB |
| 10008004 | 10004050 | 1.69 | 72 | Adjuvant (A) | 2014-02-06 | 2014-02-10 | PACLITAXEL | N | N | 10374206 | PACLITAXEL |
| 10008005 | 10004054 | null | 61.6 | Disease modification (D) | 2016-09-30 | 2017-10-20 | Rituximab (SUBCUTANEOUS Maintenance) | null | null | 10374680 | RITUXIMAB |
| 10008006 | 10004056 | 1.58 | 76.8 | Palliative (P) | 2018-08-11 | 2018-11-27 | PEMBROLIZUMAB | N | N | 10374703 | PEMBROLIZUMAB |
| 10008007 | 10004059 | 1.81 | 85.2 | Palliative (P) | null | 2016-01-08 | Docetaxel | N | null | 10375184 | DOCETAXEL |
| 10008008 | 10004064 | null | 91.3 | null | 2017-11-29 | 2018-03-11 | Trastuzumab Subcutaneous | 02 | N | 10376164 | TRASTUZUMAB |
| 10008009 | 10004066 | 1.7 | 80.2 | null | 2017-10-17 | 2017-11-07 | Trastuzumab Subcutaneous | 2 | N | 10376227 | TRASTUZUMAB |
| 10008010 | 10004068 | 1.64 | 78 | Palliative (P) | 2015-11-05 | 2015-11-16 | PEMBROLIZUMAB | N | null | 10376846 | PEMBROLIZUMAB |
| 10008011 | 10004070 | 1.63 | 96.8 | Disease modification (D) | 2018-05-12 | 2018-05-12 | Irinotecan + Modified De Gramont | 02 | N | 10377105 | IRINOTECAN + MDG |